Tivic Health Systems, Inc. (NASDAQ:TIVC) has conducted a reverse stock split at a ratio of 17 for 1 to meet Nasdaq’s minimum bid price requirement.
The current stock price of TIVC reflects a decrease of 12.67%, indicating significant price volatility over the past year.
TIVC’s market capitalization stands at approximately $2.42 million, with a trading volume of 894,535 shares on the NASDAQ exchange.
Tivic Health Systems, Inc. (NASDAQ:TIVC) is a company focused on developing and commercializing bioelectronic medicine. It aims to provide non-invasive solutions for various health conditions. TIVC competes in the medical technology sector, where innovation and regulatory compliance are crucial for success. The company recently made a significant financial decision to ensure its continued presence on the Nasdaq Capital Market.
On March 7, 2025, TIVC executed a reverse stock split at a ratio of 17 for 1. This means that for every 17 shares previously held, shareholders now own one share. The reverse stock split is a strategic move to increase the stock price and meet the minimum bid price requirement set by Nasdaq. This decision was made by the Board of Directors to maintain compliance with Nasdaq’s listing standards.
The current stock price of TIVC is $0.2558, which reflects a decrease of 12.67% with a change of $0.0371. The stock has shown volatility, with today’s price fluctuating between a low of $0.2539 and a high of $0.2855. Over the past year, TIVC’s stock price has ranged from a high of $31.45 to a low of $0.2513, indicating significant price movement.
TIVC’s market capitalization is approximately $2.42 million, which is relatively small compared to larger companies in the medical technology sector. The trading volume on the NASDAQ exchange is 894,535 shares, suggesting active trading interest. The reverse stock split is part of the company’s efforts to stabilize its stock price and maintain its Nasdaq listing.
